Key Takeaways: Ketamine For Eating Disorders
- Published data consists mostly of small case reports and series, concentrated in anorexia nervosa, and always used alongside other structured care.
- A possible supporting role only. Where ketamine may help is with the comorbid depression or anxiety that often accompanies an eating disorder.
- Ketamine is not, and should never be framed as, an appetite or weight treatment. If you are struggling, please reach out to a specialized eating-disorder service.
- Ketamine Wellness NY pricing for reference: $550 for an introductory session, $650 for a standard single session, and $3,150 for a six-session induction package.
Why Researchers Are Looking At Ketamine For Eating Disorders
Eating disorders rarely travel alone. Depression, anxiety, trauma, and obsessive, rigid thought patterns frequently accompany them. Those co-occurring features can be part of what keeps the illness entrenched.
Researchers have begun asking whether ketamine’s known effects on the glutamate system might address some of that underlying burden.
The Neuroplasticity and Comorbidity Rationale
Neuroplasticity refers to the brain’s capacity to form new connections and reorganize existing ones. Ketamine’s rapid action on glutamate receptors is thought to promote this process in ways that standard antidepressants do not.
For a person with an eating disorder who also carries significant depression, anxiety, or OCD-type rigidity, that mechanism is what draws clinical interest.
Research published in Nutrients summarizes this rationale in a narrative review of ketamine for anorexia nervosa. The authors note that the glutamate system is implicated in the cognitive rigidity and reward dysregulation seen in anorexia.
So, this makes ketamine’s glutamatergic action a plausible avenue for adjunctive study.
Comorbid Depression, Anxiety, and Rigid Thinking
Comorbid depression appears in a substantial portion of people with eating disorders. When standard antidepressant approaches have not worked, clinicians and researchers have begun exploring whether ketamine could help lift that additional burden.
When the illness is treatment-resistant, the same question becomes especially relevant. This is distinct from treating the eating disorder itself.
The frame researchers use is important: ketamine is studied as a possible way to ease co-occurring mood symptoms. This creates more room for the core, specialist-led treatment to work.
That framing must guide any conversation about ketamine eating disorder treatment.
What One Patient’s Experience Can Tell Us
A case report published in the Journal of Eating Disorders by Timek and colleagues (2024) describes a woman in her early thirties with severe anorexia nervosa and treatment-resistant depression.
She had tried multiple antidepressants, mood stabilizers, antipsychotics, and electroconvulsive therapy without meaningful improvement.
After seven IV ketamine sessions delivered over three weeks in a hospital setting, and alongside acceptance and commitment therapy, her depression scores declined significantly. She also reported greater cognitive flexibility and the disappearance of active suicidal ideation.
What was notable about her case was not that ketamine resolved the eating disorder. It did not. What it did was lift enough of the depression that she could engage more meaningfully with the rest of her care.
That is the realistic frame: ketamine as a door-opener, not a destination.
What The Evidence Actually Shows, and Its Real Limits
This is where honesty matters most. The evidence base for ketamine for anorexia and other eating disorders is genuinely preliminary. Anyone suggesting otherwise is overstating the science.
Published Case Reports and Small Series
Published data consists largely of individual cases and small case series.
- Brain Sciences Ketamine Review, 2022: Ragnhildstveit et al. in Brain Sciences (2022) provides a broader review of ketamine as a novel psychopharmacotherapy for eating disorders. The review notes encouraging but inconclusive signals across anorexia. It also includes some reports involving bulimia.
- Journal of Eating Disorders Case Series, 2022: A 2022 case series in the Journal of Eating Disorders examined group-based ketamine-assisted psychotherapy. The patients were in residential eating-disorder treatment and also had comorbid depression and anxiety. Results were described as promising within the limits of a very small group. In all cases, ketamine was an add-on within structured treatment, not a standalone approach.
- Journal of Eating Disorders Case Series, 2025: A recent 2025 exploratory case series in the Journal of Eating Disorders examined ketamine as adjuvant treatment. It found some benefit for comorbid mood symptoms. The study stressed that the findings are preliminary. Larger controlled trials are needed before broader conclusions can be drawn.
Why The Evidence Cannot Be Generalized
There are no large randomized controlled trials. Safety profiles and optimal dosing for eating-disorder populations are not established.
Findings from small anorexia case series cannot be generalized to bulimia, binge-eating disorder, ARFID, or other presentations. Reviewers across these papers are consistent on this point.
To Sum Up…
Here are hopeful early signals, particularly for the depression and anxiety accompanying eating disorders, but the science is early and far from settled.
What Ketamine Is Not, In This Context
Some readers come to this topic hoping ketamine might be a faster path to recovery. It is worth being direct about what the evidence does not support.
Not A Primary Eating Disorder Treatment
Ketamine for eating disorder treatment is investigational. It is not approved or established as a primary intervention for anorexia nervosa, bulimia, binge-eating disorder, or any other eating disorder.
Anyone offering it as a primary or standalone treatment is misrepresenting the current science and studies so far.
Not A Weight Or Appetite Intervention
Ketamine is not a weight or appetite tool, and it should never be framed that way. That framing would be both clinically inaccurate and potentially harmful.
This article does not discuss calories, weight, BMI, or dietary specifics. Neither should any responsible clinical discussion of ketamine in this context.
Not A Replacement For Specialized Care
Multidisciplinary eating-disorder care, medical monitoring, nutritional rehabilitation, and evidence-based psychotherapy, is what recovery depends on. Ketamine cannot substitute for any part of that.
The absence of that foundation makes ketamine not only inappropriate but potentially unsafe in this population.
The Realistic Role: Adjunct Support For Comorbid Mood Symptoms
Where ketamine may have a place is narrow but meaningful for the right person. As a possible adjunct, it may help address treatment-resistant depression or anxiety.
This applies only under the direct supervision of a specialist team. It also applies when those symptoms sit alongside an eating disorder and are not responding to standard approaches.
That decision belongs to the clinicians coordinating your eating-disorder care. Medical stability, appropriate psychiatric screening, and active multidisciplinary oversight are prerequisites, not optional steps.
The choice is made collectively by your care team, with your eating-disorder specialist leading.
Scolnick et al. in Eating and Weight Disorders examined a pilot study involving ketamine alongside dietary intervention in a small anorexia population.
The study noted the complexity of combining approaches. It also reinforced the need for specialist oversight and medical monitoring throughout.
How Care Could Fit Together At Ketamine Wellness NY
If you are receiving treatment from an eating-disorder team, a question may arise about whether ketamine could help with co-occurring depression or anxiety. A consultation with Ketamine Wellness NY can clarify candidacy and whether monitored IV ketamine would fit your existing plan.
Ketamine Wellness NY’s IV Ketamine Model
Ketamine Wellness NY provides IV ketamine only, in-clinic, under direct medical supervision of Dr. Qureshi. His board-certified internal medicine background includes clinical training at Brooklyn Hospital, NYU, and Henry J. Carter Hospital.
That means your safety and medical suitability are assessed with the same rigor applied to any complex or sensitive case.
A standard six-session induction series is spaced over about two to three weeks. Sessions are typically one to two weeks apart within the series. This is followed by maintenance consultations at intervals of one to three months.
The in-clinic IV model allows real-time monitoring and provider-adjustable dosing throughout each session. That is important in any population where medical complexity is elevated.
Screening, Candidacy, and Pricing
Not everyone is a candidate, and that determination requires individual assessment. Ketamine Wellness NY pricing is structured for accessibility:
- $550 for an introductory session
- $650 for a standard single session
- $3,150 for a six-session induction package
A consultation is the starting point. To explore whether ketamine is covered by insurance in your situation, our team can walk you through what documentation supports a prior authorization request.
You can also visit us at our Jackson Heights (Queens) or Great Neck (Long Island) clinic.
Frequently Asked Questions (FAQs)
Can ketamine treat an eating disorder on its own?
No. Eating disorders require specialized, coordinated, multidisciplinary care. Ketamine may only be considered as an adjunct for comorbid mood symptoms, under specialist supervision, when your eating-disorder team is directly involved.
Is ketamine dissociation safe for eating disorders?
Safety depends on medical stability, psychiatric history, and individual risk. Dissociation should be assessed case by case, with screening, specialist input, and coordination from your eating-disorder treatment team before any decision.
Which eating disorders has ketamine been studied in?
Mostly anorexia nervosa, with some case reports involving bulimia. There is not enough evidence to claim broad effectiveness across all eating-disorder diagnoses. ARFID, binge-eating disorder, and other presentations have very limited published data in this context.
How does ketamine differ for eating disorders?
For depression, especially treatment-resistant depression, evidence is much stronger, including controlled trials and FDA-approved esketamine. For eating disorders, research is still investigational, with similar mechanisms but much weaker clinical evidence.
How much does ketamine therapy cost in New York?
Ketamine Wellness NY pricing is structured for accessibility: $550 for an introductory session, $650 for a standard single session, and $3,150 for a six-session induction package. Start with an introductory IV ketamine session to discuss your clinical picture before committing to a full series.
Conclusion: Ketamine Therapy NYC
Eating disorders are among the most serious and complex illnesses in mental health. They deserve honest, careful answers, not hype.
The early research on ketamine in this context is genuinely interesting. This is particularly true for the depression and anxiety that so often accompany these conditions.
But the evidence is preliminary, the appropriate use is narrow, and specialized, multidisciplinary eating-disorder care always comes first.
If you are already in specialist care and you experience comorbid mood symptoms, Ketamine Wellness NY is glad to be part of that conversation.
Getting Advanced Help
If you or someone you care about is struggling with an eating disorder, please reach out to a specialized service. These conditions are treatable, and early, specialist-led help makes a meaningful difference.
National Alliance for Eating Disorders Helpline: 866-662-1235
The National Alliance helpline is available Monday–Friday, 9am–7pm EST. For immediate crisis support outside those hours, or for suicidal thoughts, contact the 988 Suicide and Crisis Lifeline by calling or texting 988, trained counselors are available 24 hours a day.
If your situation is due to co-occurring depression or anxiety, and you are already receiving specialized eating-disorder care, contact our team. We can discuss whether ketamine-assisted therapy could play a supporting role.
